Journal of the National Cancer Institute

IN THIS ISSUE
pp. 81-81(1)

Finding Ovarian Cancer
pp. 82-83(2)
Authors: Hartge, Patricia; Speyer, James L.

Drug Approvals 2011: Focus on Companion Diagnostics
pp. 84-86(3)
Author: Goozner, Merrill

StatBite Drugs In Development By Therapeutic Area (2010)
pp. 86-86(1)

ALK Gene Amplified in Most Inflammatory Breast Cancers
pp. 87-88(2)
Author: Tuma, Rabiya S.

Adoptive Immunotherapy Poised To Deliver on Decades-Old Promise
pp. 88-90(3)
Author: Hede, Karyn

Next Steps in Clinical Trial Redesign
pp. 90-92(3)
Author: Nicholas, Joanne

Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies
pp. 93-113(21)
Authors: Eisen, Tim; Sternberg, Cora N.; Robert, Caroline; Mulders, Peter; Pyle, Lynda; Zbinden, Stephan; Izzedine, Hassan; Escudier, Bernard

Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner Notes
pp. 114-124(11)
Authors: Lim, Anita W. W.; Mesher, David; Gentry-Maharaj, Aleksandra; Balogun, Nyaladzi; Jacobs, Ian; Menon, Usha; Sasieni, Peter

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
pp. 125-132(8)
Authors: Andriole, Gerald L.; Crawford, E. David; Grubb, Robert L.; Buys, Saundra S.; Chia, David; Church, Timothy R.; Fouad, Mona N.; Isaacs, Claudine; Kvale, Paul A.; Reding, Douglas J.; Weissfeld, Joel L.; Yokochi, Lance A.; OBrien, Barbara; Ragard, Lawrence R.; Clapp, Jonathan D.; Rathmell, Joshua M.; Riley, Thomas L.; Hsing, Ann W.; Izmirlian, Grant; Pinsky, Paul F.; Kramer, Barnett S.; Miller, Anthony B.; Gohagan, John K.; Prorok, Philip C.

YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth
pp. 133-146(14)
Authors: Lasham, Annette; Samuel, Weini; Cao, Helen; Patel, Rachna; Mehta, Reena; Stern, J. Lewis; Reid, Glen; Woolley, Adele G.; Miller, Lance D.; Black, Michael A; Shelling, Andrew N.; Print, Cristin G.; Braithwaite, Antony W.

InterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markers
pp. 147-158(12)
Authors: Sitas, Freddy; Egger, Sam; Urban, Margaret I.; Taylor, Philip R.; Abnet, Christian C.; Boffetta, Paolo; OConnell, Dianne L.; Whiteman, David C.; Brennan, Paul; Malekzadeh, Reza; Pawlita, Michael; Dawsey, Sanford M.; Waterboer, Tim; Webb, Penelope M.; Green, Adle C.; Hayward, Nicholas K.; Zaridze, David; Holcatova, Ivana; Mates, Dana; Szeszenia-Dabrowska, Neonila; Ferro, Gilles; Janout, Vladimir; Curado, Maria Paula; Menezes, Ana Maria; Koifman, Sergio; Islami, Farhad; Nasrollahzadeh, Dariush; Hu, Nan; Goldstein, Alisa M.; Gao, Ying; Ding, Ti; Kamangar, Farin

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria
pp. 159-162(4)
Authors: Perez, Edith A.; Dueck, Amylou C.; McCullough, Ann E.; Reinholz, Monica M.; Tenner, Kathleen S.; Davidson, Nancy E.; Gralow, Julie; Harris, Lyndsay N.; Kutteh, Leila A.; Hillman, David W.; Jenkins, Robert B.; Chen, Beiyun

Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
pp. 163-163(1)
Authors: Mikolajczyk, Rafael T.; Horn, Johannes; Damm, Oliver; Kaufmann, Andreas M.; Kretzschmar, Mirjam E. E.

Response: Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
pp. 163-164(2)
Authors: Safaeian, Mahboobeh; Wacholder, Sholom; Hildesheim, Allan